Proffitt & Goodson Inc Viatris Inc Transaction History

Proffitt & Goodson Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$9.95 - $12.27 $2,397 - $2,957	-241 Reduced 96.4%	9 $0
Q1 2022 May 09, 2022	SELL	$9.81 - $15.4 $647 - $1,016	-66 Reduced 20.89%	250 $3,000
Q4 2021 Jan 28, 2022	SELL	$12.09 - $14.68 $1,765 - $2,143	-146 Reduced 31.6%	316 $4,000
Q3 2021 Nov 01, 2021	SELL	$13.25 - $15.13 $1,391 - $1,588	-105 Reduced 18.52%	462 $6,000
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $4,085 - $5,087	-315 Reduced 35.71%	567 $8,000
Q1 2021 May 03, 2021	SELL	$13.59 - $18.54 $10,056 - $13,719	-740 Reduced 45.62%	882 $12,000
Q4 2020 Jan 25, 2021	BUY	$14.3 - $18.74 $23,194 - $30,396	1,622 New	1,622 $30,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

Stay updated on Proffitt & Goodson Inc with notifications on news.